Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.370
-0.020 (-0.84%)
Jul 31, 2025, 4:00 PM - Market closed
Intra-Cellular Therapies Market Cap
Adverum Biotechnologies has a market cap or net worth of $49.51 million as of August 1, 2025. Its market cap has decreased by -73.27% in one year.
Market Cap
49.51M
Enterprise Value
60.02M
1-Year Change
-73.27%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $49.51M, a decrease of -91.49%. That is a compound annual growth rate of -20.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 49.90M | -48.61% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
| Jul 31, 2014 | 581.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |